StonvexLoading…
StonvexStonvexStonvexCore line items from DCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 (Est.) Expected 2026-06-02 | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Annual 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|---|
Revenue | $983.38M | $1.83B | $935.40M | $3.69B | $2.71B |
Operating Income | Not available | $268.00M | $149.30M | $495.40M | $343.70M |
Net Income | Not available | $206.40M | $113.90M | $367.00M | $252.70M |
EPS (Diluted) | $1.06 | $1.75 | $0.97 | $3.05 | $2.09 |
Total Assets | Not available | $3.06B | $3.03B | $2.98B | $3.00B |
Total Liabilities | Not available | $1.49B | $1.51B | $1.52B | $1.53B |
Cash & Equivalents | Not available | $194.40M | $210.70M | $180.40M | $178.50M |
Free Cash Flow OCF − CapEx | Not available | $129.20M | $111.20M | $339.90M | $192.40M |
Shares Outstanding | Not available | 117.80M | 117.80M | 120.40M | 121.20M |